试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
Tinostamustine Conditioning and Autologous Stem Cell
编号:NCT03687125登记状态:提前终止企业 / 申办者:Mundipharma-EDO GmbH
药物 / 成分:Tinostamustine、Autologous Stem Cell Transplant (ASCT)
登记的停止原因(原文):Sponsor decision based on adverse events limiting administration of higher doses required to achieve myeoblative conditioning necessary in this population
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization
编号:NCT03732469登记状态:提前终止企业 / 申办者:University of South Florida
药物 / 成分:Acetaminophen、Fentanyl、Propofol
登记的停止原因(原文):Significant change in our clinic structure prevented continued recruitment of patients to the study
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke
编号:NCT03763929登记状态:提前终止企业 / 申办者:Diffusion Pharmaceuticals Inc
药物 / 成分:Trans-Sodium Crocetinate、Placebo
登记的停止原因(原文):The study was stopped due to lack of meaningful enrollment due to the COVID-19 pandemic.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
编号:NCT03809650登记状态:提前终止企业 / 申办者:Actelion
药物 / 成分:macitentan 10 mg
登记的停止原因(原文):Due to a change in the development strategy
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol
编号:NCT04039919登记状态:提前终止企业 / 申办者:UCB Biopharma S.P.R.L.
药物 / 成分:Padsevonil、Placebo (PSL)
登记的停止原因(原文):Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
编号:NCT04091737登记状态:提前终止企业 / 申办者:CSL Behring
药物 / 成分:Autologous enriched CD34+ cell fraction that contains CD34+ cells transduced with lentiviral vector encoding human γ-globinG16D and short-hairpin RNA734
登记的停止原因(原文):Unanticipated delays, not for safety reasons
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants
编号:NCT04126343登记状态:提前终止企业 / 申办者:UCB Biopharma S.P.R.L.
药物 / 成分:Padsevonil、Moxifloxacin、Placebo
登记的停止原因(原文):Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
编号:NCT04192513登记状态:提前终止企业 / 申办者:DermBiont, Inc.
药物 / 成分:J. lividum
登记的停止原因(原文):Covid-19 has shut the clinic indefinitely
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-18
A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis
编号:NCT04315051登记状态:提前终止企业 / 申办者:DermBiont, Inc.
药物 / 成分:Cohort 1 J. Lividum、Placebo Gel
登记的停止原因(原文):Covid- 19 has shut the clinic
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2021-06-16
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
编号:NCT02046187登记状态:提前终止企业 / 申办者:St. Joseph's Hospital and Medical Center, Phoenix
药物 / 成分:Ketogenic Diet、Radiation therapy、Temozolomide
登记的停止原因(原文):excessive protocol deviations due to strict nature of diet requirements
查看官方原始记录 ↗